P

Inventor

SKEGRO DARKO

CH13 patents
⚠️ This page may combine multiple inventors who share the name “SKEGRO DARKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

Ichnos Sciences SA

4 patents
US11773166B2Oct 3, 2023

CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production

Ichnos Sciences SA5 citations83
US11891454B2Feb 6, 2024

Production of T cell retargeting hetero-dimeric immunoglobulins

Ichnos Sciences SA3 citations72
US11851502B2Dec 26, 2023

Production of T cell retargeting hetero-dimeric immunoglobulins

Ichnos Sciences SA3 citations71
US12006367B2Jun 11, 2024

CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production

Ichnos Sciences SA0 citations60

GLENMARK PHARMACEUTICALS SA

3 patents
US9493563B2Nov 15, 2016

Production of T cell retargeting hetero-dimeric immunoglobulins

GLENMARK PHARMACEUTICALS SA47 citations96
US9683053B2Jun 20, 2017

Hetero-dimeric immunoglobulins

GLENMARK PHARMACEUTICALS SA38 citations91
US9290576B2Mar 22, 2016

Antibodies that bind to TL1A and their uses

GLENMARK PHARMACEUTICALS SA22 citations89

BLEIN STANISLAS

3 patents
US9683052B2Jun 20, 2017

Hetero-dimeric immunoglobulins

BLEIN STANISLAS26 citations90
US8679492B2Mar 25, 2014

Humanized antibodies that bind to CD19 and their uses

BLEIN STANISLAS35 citations88
US8975376B2Mar 10, 2015

Anti-alpha2 integrin antibodies and their uses

BLEIN STANISLAS7 citations82

NOVARTIS AG

2 patents
US12522654B2Jan 13, 2026

Engineered heterodimeric proteins

NOVARTIS AG0 citations55
US11685776B2Jun 27, 2023

Engineered heterodimeric proteins

NOVARTIS AG0 citations55

SANOFI SA

1 patent
US11267891B2Mar 8, 2022

Fc variant antibodies and their uses

SANOFI SA0 citations61